CV Sciences (CVSI) Total Debt (2013 - 2026)

CV Sciences (CVSI) reported Total Debt of $72000.0 for Q1 2026, down 94.32% on a YoY basis from $1.3 million in Q1 2025, and down 95.63% sequentially from $1.6 million in Q4 2025.

CV Sciences (CVSI) Total Debt (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 11 years of Total Debt data on file, last reported at $72000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Total Debt fell 94.32% year-over-year to $72000.0; the trailing twelve-month figure through Mar 2026 stood at $72000.0 (down 94.32% YoY), and the FY2025 full-year result was $1.6 million, up 143.57% from the prior year.
  • Total Debt eased to $72000.0 in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.7 million in Q1 2022 to a low of $72000.0 in Q1 2026.
  • A 4-year average of $1.2 million and a median of $1.3 million in 2025 frame the typical range for Total Debt.
  • Across the five-year window, Total Debt surged 375.21% in 2022 and slumped 94.32% in 2026, its largest moves.
  • Tracing CVSI's Total Debt over 4 years: stood at $1.7 million in 2022, then plunged by 60.75% to $677000.0 in 2024, then soared by 143.57% to $1.6 million in 2025, then sank by 95.63% to $72000.0 in 2026.
  • Business Quant data shows CVSI's Total Debt at $72000.0 in Q1 2026, $1.6 million in Q4 2025, and $955000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 11.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.63 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 28.76 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.34 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.81 Bn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn 72,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 72,000.00
Dec 31, 2025 1.65 Mn
Sep 30, 2025 955,000.00
Jun 30, 2025 1.23 Mn
Mar 31, 2025 1.27 Mn
Dec 31, 2024 677,000.00
Dec 31, 2022 1.73 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 1.73 Mn
Dec 31, 2021 771,000.00
Mar 31, 2021 363,000.00
Sep 30, 2020 2.54 Mn
Jun 30, 2020 2.91 Mn
Mar 31, 2018 1.17 Mn
Dec 31, 2017 2.19 Mn
Sep 30, 2017 1.14 Mn
Jun 30, 2017 1.35 Mn
Mar 31, 2017 718,595.00
Dec 31, 2016 805,138.00
Sep 30, 2016 2.61 Mn